Every material Form 8-K ULTRALIFE CORP has filed with the SEC since May 08, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
Ultralife agreed on October 27, 2026 to be acquired by EnerSys through a two-step tender offer and merger, at $16.00 per share in cash, with a total enterprise value of approximately $320 million. The deal is expected to close in the first quarter of calendar 2027 and, if completed, would remove Ultralife's common stock from public markets.
Offer price is $16.00 per share in cash, a stated premium of 166% to the October 26, 2026 closing price
Total enterprise value is approximately $320 million; EnerSys plans to fund it with cash on hand and has no financing contingency
Termination fees of $10,300,000 apply in specified circumstances to either party; closing expected in Q1 2027, with an Outside Date of April 27, 2027
Ultralife reported second-quarter 2026 revenue of $47.9 million, down 1.3% from $48.6 million a year earlier, while GAAP earnings per share rose to $0.15 from $0.05. Gross margin improved to 28.9% from 23.9%, helped by a $1.1 million net IEEPA tariff refund, and backlog reached $117.5 million, which the company said is the highest in its history. The mix of a sales decline alongside higher profit makes the quarter's results mixed for shareholders.
Revenue was $47.9 million versus $48.6 million in Q2 2025; Battery & Energy Products sales fell 3.7% to $44.2 million, and Communications Systems sales rose 39.3% to $3.8 million.
GAAP EPS was $0.15 versus $0.05; adjusted EBITDA was $6.1 million versus $4.1 million.
Gross margin was 28.9%; excluding the $1.1 million net IEEPA refund, it was 26.6%.
Operating income was $3.4 million, including $0.9 million in one-time costs, versus $2.3 million a year earlier.
Ultralife reported first-quarter 2026 sales of $47.4 million, down 6.5% from $50.7 million a year earlier, and an operating loss of $0.2 million compared with operating income of $3.4 million. The company cited a power outage, lost production days at its Raynham, MA facility, and weak Communications Systems orders, and said its record backlog of $115.1 million gives it a basis to restore profitability in 2026.
Sales were $47.4 million versus $50.7 million; Communications Systems sales fell 25.7% to $3.3 million.
GAAP EPS was ($0.03) versus $0.11, and adjusted EBITDA was $3.2 million versus $5.4 million.
Operating result included one-time costs of $1.7 million; gross margin fell to 21.3% from 25.1%.
Backlog reached $115.1 million, up from $110.2 million at the end of 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every ULTRALIFE CORP filing is on SEC EDGAR ↗. 8-K briefs of other companies →